Companies: 10,795·Total market cap: $144.5T
Yubo International Biotech Limited

Yubo International Biotech Limited

YBGJOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$1006454
P/E Ratio—
52W High$0.1776
52W Low$0.0079
Overview
Foreign Private Issuer · Files 20-F / 6-K

Yubo International Biotech Limited (YBGJ) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000895464 · YBGJ · OTC · as of Jun 15, 2026

Filing snapshot

283
Total Filings
ARS
Latest Form
2026-06-12
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000895464 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-31
Fiscal Year End
Mar 31, 2026
Accession No.
0001640334-26-000598
Primary Document
yubo_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000895464 · Accession 0001640334-26-000598

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
FORM 8-K
2026-01-16Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
ARSARS
ARS
2026-06-12
View
DEF 14CDEF 14C
DEF 14C
2026-06-12
View
10-QQuarterly Report
FORM 10-Q
2026-05-15
View
10-KAnnual Report
FORM 10-K
2026-03-31
View
8-KCurrent Report
FORM 8-K
2026-01-16
View
10-QQuarterly Report
FORM 10-Q
2025-11-14
View
10-QQuarterly Report
FORM 10-Q
2025-08-13
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-07-25
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-07-25
View
8-KCurrent Report
FORM 8-K
2025-07-25
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2025-06-03
View
10-QQuarterly Report
FORM 10-Q
2025-05-14
View
3Initial Statement of Beneficial Ownership
FORM 3
2025-05-05
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-04-25
View
DEF 14CDEF 14C
DEF 14C
2025-04-14
View
Showing 1–15 of 268 filingsForm 4 / 144 hidden· 283 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000895464  |  Exchange: OTC · Healthcare

Yubo International Biotech Limited (OTC: YBGJ) has submitted 283 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0000895464, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Yubo International Biotech Limited's most comprehensive regulatory disclosure. The most recent Yubo International Biotech Limited 10-K was filed on 2026-03-31 for fiscal year ending 2026. Historical YBGJ 10-K annual reports are available from 1996 through 2026.

Investors researching Yubo International Biotech Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-15
Related Companies SEC Filings — Healthcare
SHMN SEC Filings →ANTCF SEC Filings →IVRO SEC Filings →EVIO SEC Filings →HEMP SEC Filings →MITI SEC Filings →MSIU SEC Filings →BHNGF SEC Filings →
→ YBGJ Financials→ YBGJ Earnings→ YBGJ Insider Trades

Frequently Asked Questions

YBGJ SEC Filings · 8 questions

Yubo International Biotech Limited (YBGJ) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 283 filings and access original documents at no cost. Yubo International Biotech Limited's CIK is 0000895464.

YBGJ SEC filingsYubo International Biotech Limited SEC documentsfind YBGJ 10-K